Dr. Sarah Mitchell
Pharmacologist and translational research leader with 12+ years of experience in oncology, drug discovery, biomarker development, pharmacokinetics, pharmacodynamics, and IND-enabling studies. Experienced in leading CRO collaborations, FDA submissions, GLP studies, and multidisciplinary teams. Published author with expertise in in vivo and in vitro pharmacology.
Sara Elkashef
Pharmacologist and translational drug-development leader (PhD, PharmD) with more than a decade of experience moving assets from discovery to IND and FIH across oncology, radiopharmaceuticals, immuno-oncology, genetic engineering, and precision medicine. I lead cross-functional pharmacology/biomarker strategy, direct GLP/GCLP studies, and author CTD modules for FDA, EMA, and Health Canada. Led more than 25 preclinical programs; […]